Increases PD-L1 expression on tumour cells; stimulates the recruitment of NK cells and reovirus-specific CD8+ T cells to the tumour site; Modifying virus to antagonize inhibitory mechanisms within the TME (e.g. mutations in viral cell attachment protein σ1 gene). Here, CD8A is linked to neoplasm.